Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC appeal on treatment for ultra-rare blood disease


New Zealanders rallying PHARMAC for life-saving treatment for ultra-rare blood disease


Eight Kiwis battling an ultra-rare blood disease that claims the lives of one-in-three patients within five years of diagnosis, if untreated, will be appealing to PHARMAC this Thursday, January 24, to save their lives.


A life-saving treatment renowned for its powerful reversal of disease progression, is available under funding arrangements in more than 40 countries world-wide.

Yet New Zealand remains an anomaly – the only country in the advanced OECD not funding the treatment for its citizens.

If these Kiwis don’t get access to this treatment, they will die. It’s simply a matter of time.

Their only hope for survival rests in the hands of NZ government medicines-funding agency, PHARMAC.

ENDS

Download full media kit THURS, JAN 24 @ www.pnhsanz.org.nz/media


Click for big version.
Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.